| P50 | author | Anthony A. Grace | Q28823334 |
| | Gemma Modinos | Q63987320 |
| | Paul Allen | Q37834596 |
| | Philip McGuire | Q37834611 |
| P2860 | cites work | The dopamine hypothesis of schizophrenia: version III--the final common pathway | Q22242827 |
| | Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 |
| | GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression | Q24610466 |
| | The hippocampal-prefrontal pathway: the weak link in psychiatric disorders? | Q26822528 |
| | Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation | Q27320072 |
| | Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 |
| | Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 |
| | Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia | Q30429962 |
| | Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals | Q30447851 |
| | Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis | Q30450082 |
| | Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations | Q30455338 |
| | A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia | Q30465716 |
| | Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis | Q30466268 |
| | Dopaminergic dysfunction in schizophrenia: salience attribution revisited. | Q30475711 |
| | Sustained activation of the hippocampus in response to fearful faces in schizophrenia. | Q50971006 |
| | Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis. | Q51032268 |
| | Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics | Q60644228 |
| | Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy | Q71410459 |
| | Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia | Q73535859 |
| | Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies | Q73815830 |
| | Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. | Q45950519 |
| | Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study. | Q45999628 |
| | Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. | Q46022290 |
| | Elevated striatal dopamine function linked to prodromal signs of schizophrenia | Q46174418 |
| | Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state | Q46349634 |
| | Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain | Q46599084 |
| | HPA axis functioning associated with transition to psychosis: combined DEX/CRH test | Q46887505 |
| | Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. | Q46945434 |
| | Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia | Q46974035 |
| | The rat prefrontostriatal system analyzed in 3D: evidence for multiple interacting functional units. | Q48107164 |
| | Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. | Q48121459 |
| | Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study | Q48152135 |
| | Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis | Q48278378 |
| | Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis | Q48394255 |
| | Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia | Q48395602 |
| | Dopamine D2 densities and the schizophrenic brain. | Q48404440 |
| | Absolute coding of stimulus novelty in the human substantia nigra/VTA. | Q48436853 |
| | Non-reduction in hippocampal volume is associated with higher risk of psychosis | Q48457063 |
| | Hippocampal novelty activations in schizophrenia: disease and medication effects | Q48581541 |
| | Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia | Q48723751 |
| | An fMRI study of "theory of mind" in at-risk states of psychosis: comparison with manifest schizophrenia and healthy controls | Q48731158 |
| | Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness | Q48891953 |
| | Increased brain dopamine and dopamine receptors in schizophrenia. | Q48903689 |
| | Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. | Q48948657 |
| | Blunted cortisol awakening response in people at ultra high risk of developing psychosis. | Q50631753 |
| | Maternal separation results in early emergence of adult-like fear and extinction learning in infant rats. | Q50643617 |
| | Overactivation of fear systems to neutral faces in schizophrenia. | Q50802890 |
| | Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. | Q50803831 |
| | Increased neural response related to neutral faces in individuals at risk for psychosis. | Q50876145 |
| | Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia. | Q50950002 |
| | Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models | Q30476810 |
| | Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia | Q30478274 |
| | The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal | Q30499888 |
| | Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data | Q30711472 |
| | Do we still believe in the dopamine hypothesis? New data bring new evidence | Q30906669 |
| | Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies | Q31023592 |
| | Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies | Q31043017 |
| | Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies | Q32082435 |
| | Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings | Q33425487 |
| | Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysis. | Q33530424 |
| | Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders | Q33555684 |
| | Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia | Q33563154 |
| | Resting-state perfusion in nonmedicated schizophrenic patients: a continuous arterial spin-labeling 3.0-T MR study | Q33588407 |
| | Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia | Q33718088 |
| | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 |
| | Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume | Q33849008 |
| | Meta-analysis of regional brain volumes in schizophrenia | Q33885349 |
| | To model a psychiatric disorder in animals: schizophrenia as a reality test | Q33913794 |
| | Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies | Q33957510 |
| | Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia | Q33963430 |
| | Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI. | Q33989669 |
| | Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia | Q34048560 |
| | Elevated gamma-aminobutyric acid levels in chronic schizophrenia | Q34142882 |
| | Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. | Q34174069 |
| | Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis | Q34270086 |
| | Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. | Q34351095 |
| | Resting neural activity distinguishes subgroups of schizophrenia patients | Q34356672 |
| | The genomics of schizophrenia: update and implications. | Q34381708 |
| | Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. | Q34424470 |
| | Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients | Q34429796 |
| | From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis. | Q34432432 |
| | Dopamine-mediated disinhibition in the CA1 region of rat hippocampus via D3 receptor activation. | Q34450964 |
| | Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals | Q34492046 |
| | Dopamine in schizophrenia: a review and reconceptualization | Q34568816 |
| | Calcium and excitotoxic neuronal injury. | Q40586805 |
| | The medial temporal lobe in schizophrenia | Q41581012 |
| | Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. | Q42519170 |
| | Neuropharmacological and neurobiological relevance of in vivo ¹H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders | Q42544819 |
| | Subanesthetic doses of ketamine stimulate psychosis in schizophrenia | Q42557972 |
| | The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat. | Q42620039 |
| | Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis | Q42967481 |
| | Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study | Q42984373 |
| | Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study. | Q43095693 |
| | Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study | Q43851337 |
| | Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study | Q43987270 |
| | Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers | Q44201512 |
| | Structural and metabolic changes in language areas linked to formal thought disorder. | Q44251481 |
| | Glutamate-receptor-mediated encoding and retrieval of paired-associate learning | Q44508738 |
| | Whole-brain mapping of direct inputs to midbrain dopamine neurons | Q44901176 |
| | Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens | Q44938375 |
| | Preserved working memory and altered brain activation in persons at risk for psychosis. | Q45329878 |
| | Regional gray matter volume abnormalities in the at risk mental state | Q34572449 |
| | Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk | Q34636460 |
| | Connectivity-based segregation of the human striatum predicts personality characteristics | Q34887650 |
| | Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis | Q35158156 |
| | Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia | Q35175354 |
| | Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia | Q35230683 |
| | A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP. | Q35244029 |
| | The primate basal ganglia: parallel and integrative networks | Q35631862 |
| | Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator | Q35760205 |
| | The principal features and mechanisms of dopamine modulation in the prefrontal cortex | Q35894171 |
| | The hippocampal-VTA loop: controlling the entry of information into long-term memory | Q36144286 |
| | NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia | Q36245009 |
| | Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis | Q36442025 |
| | Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. | Q36871782 |
| | Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study | Q36928703 |
| | Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. | Q36941951 |
| | Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride | Q36942898 |
| | Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study | Q37001281 |
| | The nature of dopamine dysfunction in schizophrenia and what this means for treatment | Q37062793 |
| | Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia | Q37103318 |
| | Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study | Q37215695 |
| | Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis | Q37228333 |
| | A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia | Q37369353 |
| | Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver | Q37665156 |
| | Glutamate and GABA imbalance promotes neuronal apoptosis in hippocampus after stress | Q37685583 |
| | The Hippocampal Formation in Schizophrenia | Q37784600 |
| | MR spectroscopy in schizophrenia | Q37958837 |
| | Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis | Q38182624 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 129-138 | |
| P577 | publication date | 2014-12-30 | |
| P1433 | published in | Trends in Neurosciences | Q3538443 |
| P1476 | title | Translating the MAM model of psychosis to humans | |
| P478 | volume | 38 | |